I. D. Magamedov

I. D. Magamedov

Auto-generated profile, based on publicly available information

I. D. Magamedov

Pavlov University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2020 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
ARA. N. Ryazanov
A. N. Ryazanov
IMI. D. Magamedov
I. D. Magamedov
VSV. V. Soroka
V. V. Soroka
SNS. P. Nokhrin
S. P. Nokhrin
EME. P. Mikhelson
E. P. Mikhelson
AKA. B. Kurilov
A. B. Kurilov
A 53-year-old male patient had extensive traumatic damage to the right lower limb in a car accident that happened 17 years ago, which subsequently led to a large amputation at the hip level. Later, adduction contracture in the right hip joint with a complex regional pain syndrome developed. Due to the ineffectiveness of various methods of conservative treatment, it was decided to perform right-sided lumbar sympathectomy. Ten days later, the patient was discharged for outpatient treatment. The result of the operation was a complete relief of pain syndrome both in the early postoperative and in the long-term periods of time. Despite the large number of types of conservative therapy in modern clinical practice, none of them is perfect. Doctors decide to operate less often, trying to minimize the intervention. However, therapeutic effects are not always possible as monotherapy, often requiring additional treatments. Due to the wide development and distribution of medical products, doctors often neglect or forget about such a method as lumbar sympathectomy. Therefore, the problem of complex regional pain syndrome remains relevant today.

1 January 2021 in Clinical and Experimental Surgery. Petrovsky journal
Verified
Journal Article
Closed access
IMI.D. Magamedov
I.D. Magamedov
LPL.P. Pivovarova
L.P. Pivovarova
SNS.P. Nokhrin
S.P. Nokhrin
VSV.V. Soroka
V.V. Soroka
OAO.B. Ariskina
O.B. Ariskina
OGO.V. Goncharova
O.V. Goncharova

15 July 2026 in Regional blood circulation and microcirculation
Verified
Journal Article
Closed access
IMI. D. Magamedov
I. D. Magamedov
OAO. B. Ariskina
O. B. Ariskina
SOS. V. Ordynets
S. V. Ordynets
LPL. P. Pivovarova
L. P. Pivovarova
IOI. V. Osipova
I. V. Osipova
LSL. D. Sorokina
L. D. Sorokina
   Introduction. Inflammation is one of the leading components in the pathogenesis of acute lower limb ischemia (ALLI). Interleukin-18 (IL-18), a pleiotropic proinflammatory cytokine that regulates innate and adaptive immune responses, plays a significant role in the development of chronic inflammation in atherosclerosis, creating the prerequisites for the development of ALLI. Increased IL-18 production causes autoinflammation, destabilization of atherosclerotic plaques, development of thrombosis and ALLI.    Objective.  To study the contribution of interleukin-18 during ALLI, its relationship with markers of inflammation, lipid metabolism, tissue destruction and endothelial dysfunction.   Materials and Methods.  71 patients with ALLI and basic therapy aged 70 (60; 83) years and 15 patients aged 75 (77; 88) years with vasaprostan therapy were examined in the Department of Vascular Surgery of the I. I. Dzhanelidze Research Institute of Emergency Care. The comparison group consisted of volunteers of the same age. On admission to the department before surgery, on days 1 and 10 after reconstructive surgery the following blood levels were examined: cytokines IL-6, IL-10, IL-18, C-reactive protein; tissue damage factors (creatine kinase, myoglobin) and endothelial dysfunction factor (homocysteine), glucose, total protein, and blood lipids.    Results.  After surgery, an increase in C-reactive protein and inflammatory cytokines, as well as signs of energy deficiency (hyperglycemia, hypopoproteinemia, and hypolipidemia) was observed. An increase in creatine kinase activity, myoglobin and homocysteine levels was more pronounced in deceased patients. The use of vasaprostan reduces inflammatory markerscompared to baseline therapy.    Conclusion. IL-18 plays a significant role in the development of inflammation in ALLI. Vasaprostan therapy reduces C-reactive protein levels, inflammatory cytokines, and systemic inflammation and can be recommended for the treatment of ALLI.

1 June 2023 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
IMI. D. Magamedov
I. D. Magamedov
LPL. P. Pivovarova
L. P. Pivovarova
SPS. A. Platonov
S. A. Platonov
SOS. V. Ordynets
S. V. Ordynets
SNS. P. Nokhrin
S. P. Nokhrin
TIT. A. Isaev
T. A. Isaev
Leukocyte-platelet adhesion during hypoxia, tissue damage, activation of inflammation and coagulation is associated with the expression of ICAM-1 membrane molecules and integrins by blood and tissue cells. At the same time, platelet adhesion receptors determine their adhesion to the endothelium and recruited lymphocytes. The role of platelets in the pathogenesis of ischemic cardiovascular diseases also consists in their ability to modulate both hemostasis and inflammatory reactions, which is accompanied by the secretion of inflammatory mediators and factors that promote the recruitment of leukocytes to tissue damage sites. Purpose of the study: to study the effect of the synthetic glucocorticoid dexamethasone on the expression of adhesion receptors CD18+ and CD54+ on leukocytes, the content of platelets and fibrinogen in the blood of patients with ALLI, the relationship of these indicators with the severity and outcome of the disease.To study the effect of anti-inflammatory therapy, a group of 32 patients treated with dexamethasone was formed; the comparison group was represented by 71 patients with basic therapy, the control group consisted of 15 volunteers. After revascularization, all patients received antiplatelet and anticoagulant therapy. Dexamethasone infusions were carried out in a course of 4 to 6 days after reconstructive surgery. In all patients, the content of C-reactive protein in the blood, the content of platelets and fibrinogen were determined. The number of lymphocytes expressing adhesion molecules ICAM-1 (CD54+) and integrins (CD18+) was counted using the immunocytochemical method. Studies were performed before surgery and on days 1, 3, 7, and 10 after surgery.With exacerbation of ischemia and damage to the endothelium, the accumulation of cytolysis products, the expression of adhesion molecules increases both on endotheliocytes and on inflammatory effector cells – leukocytes and platelets. Adhesion molecules conduct an activation signal inside the cell, which promotes adhesion of leukocytes and platelets to the endothelium, lymphocytic-platelet adhesion, the formation of a parietal thrombus, and possible occlusion of damaged vessels. Increased expression of adhesion molecules is associated with the activation of metabolism, inflammation, coagulation and oxidative stress, stimulates all hematopoietic lineages, including platelets. The level of involvement of cellular reactions in the pathogenesis of the disease affects the effectiveness and duration of treatment, the risk of recurrent thrombosis and death. Anti-inflammatory therapy with dexamethasone contributed to earlier remission, a decrease in the proportion of infectious complications, such as wound suppuration from 10% to 6%, the number of necessary amputations from 32% to 16%, the frequency of deaths from 31% to 6%, and a reduction in hospital stay from 13 days to 10.Inflammation, adhesiveness of effector cells and thrombosis are important factors in the pathogenesis of acute lower limb ischemia. Therapy with dexamethasone helps to reduce the level of systemic inflammatory response, the number of necessary amputations, the number of complications and adverse outcomes in the treatment of ALLI, and reduce the length of stay in the hospital.